Biogen Inc. (NASDAQ:BIIB)

The period between 2017 and 2021 demonstrates significant fluctuations in financial performance as measured by economic profit. Net operating profit after taxes (NOPAT) and invested capital both generally increased from 2017 to 2019, but then experienced declines, with NOPAT showing a particularly substantial decrease in 2021. The cost of capital remained relatively stable, decreasing slightly over the observed timeframe. These movements have a clear impact on the calculated economic profit.

NOPAT Trend

Net operating profit after taxes increased substantially from US$2,890,089 thousand in 2017 to US$6,023,385 thousand in 2019, representing a significant improvement in operational profitability. However, NOPAT decreased to US$4,370,868 thousand in 2020 and experienced a dramatic decline to US$1,501,467 thousand in 2021. This suggests a weakening of core operational performance in the latter years of the period.

Cost of Capital Trend

The cost of capital exhibited a minor decreasing trend, moving from 9.44% in 2017 to 8.59% in 2021. While the changes are relatively small, a lower cost of capital generally contributes positively to economic profit, all other factors being equal. The stability of this metric suggests consistent market perceptions of risk associated with the company’s capital structure.

Invested Capital Trend

Invested capital increased from US$12,476,129 thousand in 2017 to US$14,142,400 thousand in 2019, indicating growth in the company’s asset base. A decrease was observed in 2020 to US$12,625,400 thousand, followed by an increase to US$13,824,500 thousand in 2021. These fluctuations suggest changes in capital allocation strategies or asset turnover.

Economic Profit Trend

Economic profit mirrored the trend in NOPAT, increasing from US$1,712,490 thousand in 2017 to a peak of US$4,701,398 thousand in 2019. Subsequently, economic profit declined to US$3,261,678 thousand in 2020 and experienced a substantial reduction to US$313,754 thousand in 2021. This indicates that while the company generated returns exceeding its cost of capital throughout the period, the magnitude of that excess diminished considerably in the final two years. The significant drop in 2021 warrants further investigation to determine the underlying causes.

Overall, the period began with strong economic profit growth driven by increasing NOPAT and invested capital. However, the latter part of the period is characterized by declining NOPAT and fluctuating invested capital, resulting in a substantial decrease in economic profit. The relatively stable cost of capital did not offset the negative impact of reduced operational profitability.

Net Income Attributable to Biogen Inc.

The net income exhibited a rising trend from 2017 to 2019, increasing from approximately 2.54 billion to nearly 5.89 billion US dollars. However, a decline was observed starting in 2020, with net income falling to about 4.00 billion and further decreasing sharply to approximately 1.56 billion US dollars in 2021. This indicates a significant reduction in profitability during the latter years of the period.

Net Operating Profit After Taxes (NOPAT)

The NOPAT followed a similar trajectory to net income, showing an increase from about 2.89 billion US dollars in 2017 to a peak of approximately 6.02 billion US dollars in 2019. Subsequently, a decline occurred with NOPAT decreasing to roughly 4.37 billion in 2020 and then sharply dropping to around 1.50 billion US dollars in 2021. This pattern signifies a reduction in operating efficiency and effectiveness in generating profit after taxes over the last two years.

Overall Observations

Both net income and NOPAT demonstrated growth during the initial three years, suggesting improved financial performance and operational results. The peak in 2019 represents the highest point in profitability within the analyzed period. The subsequent decline in 2020 and more pronounced drop in 2021 highlight challenges or adverse developments affecting profitability and operational outcomes. The data suggests the company experienced a notable downturn in earning capacity and operating profit in the final years.

Income Tax Expense

The income tax expense demonstrates a consistent downward trend from 2017 to 2021. Starting at 2,458,700 thousand US dollars in 2017, the expense decreased significantly each year to reach 52,500 thousand US dollars in 2021. The reduction is particularly notable in 2021, where the expense dropped sharply compared to previous years.

Cash Operating Taxes

Cash operating taxes also show a general decline over the analyzed period. Beginning at 2,441,355 thousand US dollars in 2017, these taxes declined steadily year over year, falling to 533,599 thousand US dollars in 2021. The reduction is gradual until 2020, followed by a less steep but still notable decrease in 2021.

Comparative Analysis

Both income tax expense and cash operating taxes have followed a downward trajectory, reflecting a possible strategic or operational improvement affecting taxable income or tax planning. The income tax expense decreased more sharply between 2020 and 2021 compared to prior years, whereas cash operating taxes reduced more steadily across the entire timeframe.

Total Reported Debt & Leases

The total reported debt and leases remained relatively stable from 2017 to 2019, with a slight decrease each year from approximately 6.45 billion US dollars to around 6.44 billion US dollars. However, there was a significant increase in 2020, rising to approximately 7.91 billion US dollars. In 2021, the debt slightly decreased to about 7.69 billion US dollars, indicating a reduction after the peak the previous year.

Total Biogen Inc. Shareholders’ Equity

Shareholders' equity showed a consistent upward trend from 2017 to 2019, growing from approximately 12.61 billion US dollars to 13.34 billion US dollars. In 2020, there was a notable decline to about 10.70 billion US dollars. This followed by a modest recovery in 2021, with equity increasing to approximately 10.90 billion US dollars, yet still below the peak levels observed in 2019.

Invested Capital

Invested capital experienced steady growth from 2017 through 2019, rising from approximately 12.48 billion US dollars to 14.14 billion US dollars. In 2020, invested capital dropped to about 12.63 billion US dollars but rebounded in 2021 to 13.82 billion US dollars. This pattern suggests some disruptions or adjustments during 2020, followed by partial recovery the following year.

The economic spread ratio exhibited a fluctuating pattern over the observed five-year period. Initially, the ratio demonstrated substantial growth, followed by a significant decline in the most recent year.

Economic Spread Ratio Trend

In 2017, the economic spread ratio stood at 13.73%. This value increased considerably to 25.94% in 2018, indicating an improved ability to generate returns exceeding the cost of capital. The ratio continued its upward trajectory, reaching a peak of 33.24% in 2019, representing the highest level within the analyzed timeframe. A subsequent decrease to 25.83% was observed in 2020. However, the most pronounced change occurred in 2021, with the ratio falling sharply to 2.27%, signifying a substantial reduction in the spread between returns and the cost of capital.

The economic spread ratio’s decline in 2021 warrants further investigation. While economic profit decreased significantly, the invested capital also experienced a moderate increase. The combined effect of these changes resulted in the substantial drop in the economic spread ratio, suggesting a diminished capacity to generate value for investors during that year.

Relationship to Economic Profit and Invested Capital

The economic spread ratio’s movements correlate with changes in both economic profit and invested capital. The initial increases in the ratio coincided with substantial growth in economic profit. The decrease in 2021, despite a relatively stable invested capital base, was primarily driven by the dramatic reduction in economic profit. This suggests that the company’s profitability was the primary driver of the observed changes in the economic spread ratio.

The observed trend highlights the sensitivity of the economic spread ratio to fluctuations in economic profit. Continued monitoring of both economic profit and invested capital is recommended to understand the underlying factors influencing the ratio and to assess the company’s long-term value creation potential.

The economic profit margin exhibited a fluctuating trend over the observed five-year period. Initially, the margin demonstrated substantial growth, followed by a significant decline in the most recent year.

Economic Profit Margin Trend

In 2017, the economic profit margin stood at 13.95%. This figure increased considerably to 25.40% in 2018, indicating improved profitability relative to economic costs. The margin continued its upward trajectory, reaching a peak of 32.70% in 2019. A subsequent decrease was observed in 2020, with the margin falling to 24.26%. The most pronounced change occurred in 2021, where the economic profit margin experienced a substantial decline to 2.86%, representing a significant reduction in economic profitability.

The economic profit margin’s performance appears strongly correlated with revenue fluctuations. While economic profit increased from 2017 to 2019, revenue also increased. The decline in economic profit margin in 2020 coincided with a slight decrease in revenue, and the dramatic drop in 2021 occurred alongside a more substantial decrease in revenue. This suggests that changes in revenue have a considerable impact on the company’s ability to generate economic profit.

Revenue Relationship

Revenue increased from US$12,273,900 thousand in 2017 to US$14,377,900 thousand in 2019. Revenue decreased to US$13,444,600 thousand in 2020 and then fell sharply to US$10,981,700 thousand in 2021. This pattern mirrors the trend in economic profit margin, suggesting a strong link between top-line performance and economic profitability.

The substantial decrease in economic profit margin in 2021 warrants further investigation. While a decrease in revenue contributed to this decline, it is important to assess whether changes in the cost of capital or other economic costs also played a role. The significant drop from 24.26% to 2.86% indicates a potential shift in the company’s economic efficiency or competitive landscape.